Minphar SRL
2.0 FTEThe score of Minphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +86 % Total assets +40 % Headcount (avg FTE) +100 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Minphar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 49,586 € | ||||
| Equity | 147,427 € | ||||
| Cash | 141,689 € | ||||
| EBITDA | 77,025 € | ||||
| Total assets | 396,164 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Minphar's financial analysis
- Solvency37.2%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Minphar
Minphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0898.362.530
- VAT number
- BE0898362530
- Peppol
- Registered · 0208:0898362530 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Jun 2008
- Registered office
- 1080 Molenbeek-Saint-Jean
- Size
- Micro · 2.0 FTE
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Minphar (SRL) has been based in Molenbeek-Saint-Jean since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 49,586 € and equity of 147,427 €; its revenue is not published. With 2.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 37.2%, below the median of its sector (37.8%).
Companies similar to Minphar
Companies in the same business, of comparable size and area, outside its group.
- Mega Pharma Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 399,682 €
- Apotheek C. Boschmans Retail sale of pharmaceutical products Antwerp · balance sheet 396,221 €
- Pharmacie Dejardin Retail sale of pharmaceutical products Éghezée · balance sheet 395,975 €
- Farmalia Retail sale of pharmaceutical products Etterbeek · balance sheet 397,775 €
- Balans Retail sale of pharmaceutical products Holsbeek · balance sheet 393,498 €
- ulti med Products (Belgium) Retail sale of pharmaceutical products Roeselare · balance sheet 399,335 €
- Offipharma Retail sale of pharmaceutical products Froidchapelle · balance sheet 399,757 €
- Pharmaplus Rocourt Retail sale of pharmaceutical products Liège · balance sheet 400,037 €
Frequently asked questions about Minphar
What is the revenue of Minphar?
Minphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Minphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0898362530 for Minphar, if the company is VAT-registered. Its company number (CBE) is 0898.362.530.
Where is the registered office of Minphar?
According to the CBE register, the registered office of Minphar is in 1080 Molenbeek-Saint-Jean.
What is the equity of Minphar?
At the close of the 2025 financial year, the equity of Minphar amounts to 147,427 €, a solvency of 37.2% of total assets.
How many people work at Minphar?
2.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Minphar?
The register lists 2 active mandates at Minphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Minphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →